TY - JOUR
T1 - Irritable Bowel Syndrome
T2 - The effect of FODMAPs and meditation on pain management
AU - Cearley, Shannon M.
AU - Immaneni, Supriya
AU - Shankar, Padmini
N1 - Publisher Copyright:
© 2017 Elsevier GmbH
PY - 2017/6
Y1 - 2017/6
N2 - Introduction Irritable Bowel Syndrome (IBS) is a highly prevalent gastrointestinal disorder. Symptoms include abdominal pain, diarrhea, constipation, and bloating. IBS can significantly impact quality of life for patients. Similarity in symptoms can be attributed to other diseases, and the varied symptomatic manifestation among patients can cause physicians to have difficulty in providing a differential diagnosis, prolonging suffering. The heterogeneity of the disorder often forces physicians and patients to primarily focus on symptomatic management with pharmaceuticals, which can eventually lead to patient dissatisfaction due to the undesirable side effects sans quality of life improvement. Methods We used articles found in PubMed, National Institutes of Health, and the Centers for Disease Control and Prevention to provide a review of literature that focuses on two alternative approaches to symptom management, meditation and diet. Evidence suggests these alternative approaches to pain management can be integrated with conventional therapy to attenuate pain in IBS by inhibiting transient receptor potential channels. Results Within the last century, low FODMAP diets, along with relaxation through meditation, are areas that have received increased attention among medical professionals. Evidence suggests that dietary interventions, along with discovery and understanding of transient receptor potentials, have provided new insight into the mechanisms of action that are attributed to nociception in IBS. Conclusion In this opinion paper, we offer information on evidence-based complementary therapies that have been reported to improve patient satisfaction in the management of pain related to IBS. It would behoove physicians and patients to utilize an integrative approach that includes conventional and proven alternative therapies for IBS treatment.
AB - Introduction Irritable Bowel Syndrome (IBS) is a highly prevalent gastrointestinal disorder. Symptoms include abdominal pain, diarrhea, constipation, and bloating. IBS can significantly impact quality of life for patients. Similarity in symptoms can be attributed to other diseases, and the varied symptomatic manifestation among patients can cause physicians to have difficulty in providing a differential diagnosis, prolonging suffering. The heterogeneity of the disorder often forces physicians and patients to primarily focus on symptomatic management with pharmaceuticals, which can eventually lead to patient dissatisfaction due to the undesirable side effects sans quality of life improvement. Methods We used articles found in PubMed, National Institutes of Health, and the Centers for Disease Control and Prevention to provide a review of literature that focuses on two alternative approaches to symptom management, meditation and diet. Evidence suggests these alternative approaches to pain management can be integrated with conventional therapy to attenuate pain in IBS by inhibiting transient receptor potential channels. Results Within the last century, low FODMAP diets, along with relaxation through meditation, are areas that have received increased attention among medical professionals. Evidence suggests that dietary interventions, along with discovery and understanding of transient receptor potentials, have provided new insight into the mechanisms of action that are attributed to nociception in IBS. Conclusion In this opinion paper, we offer information on evidence-based complementary therapies that have been reported to improve patient satisfaction in the management of pain related to IBS. It would behoove physicians and patients to utilize an integrative approach that includes conventional and proven alternative therapies for IBS treatment.
KW - FODMAPs
KW - Integrative medicine
KW - Irritable Bowel Syndrome
KW - Meditation
KW - Transient receptor potentials
UR - http://www.scopus.com/inward/record.url?scp=85019706875&partnerID=8YFLogxK
U2 - 10.1016/j.eujim.2017.05.003
DO - 10.1016/j.eujim.2017.05.003
M3 - Short survey
AN - SCOPUS:85019706875
SN - 1876-3820
VL - 12
SP - 117
EP - 121
JO - European Journal of Integrative Medicine
JF - European Journal of Integrative Medicine
ER -